Initiation
We start by allocating you a dedicated medical writing / regulatory team of subject matter experts with clinical experience in your device's field of use.
SSCP writing & readability testing from an international team of clinical & regulatory experts
Find out more Or talk to us today
Need consulting support or a quote? Get in touch with us today
Our team combines medical device regulatory specialists with clinicians who are experts in writing for professional and lay audiences.
Mantra Systems takes pride in its proven SSCP framework with 100% success rate for submissions under the MDR.
A team of highly experienced regulatory professionals who will ensure compliance of your device while providing a seamless & transparent collaboration experience.
Want to talk to an expert? Send us your details and we'll get back to you…
Please thank all of your team for their brilliant efforts. Your standard of service, response time, and rigour were outstanding and I would strongly recommend you to any other potential client.
ABQuality Advisor, UK Manufacturer
A comprehensive, detailed and highly professional service.
BGRegulatory Manager, UK Manufacturer
We have developed a successful process to ensure the production of high quality EU MDR compliant SSCPs & readability reports.
We start by allocating you a dedicated medical writing / regulatory team of subject matter experts with clinical experience in your device's field of use.
The team will conduct an extensive review of all relevant input documents (e.g. CERs, Risk Management documents, PSURs, & IFUs) shared through a confidential & secure IT system.
The team will produce an SSCP report framework appropriate to the subject device including, where relevant, a patient-specific section and readability protocol.
Lead medical writers will produce a 9-section SSCP along with patient specific SSCP and readability test protocol (if relevant) using a proven structure, collating device specific information from the input documents.
The draft will be submitted for review at your pace and capacity. A review call is then held, feedback collated and adjustments made.
After your approval, the readability test starts and the results are analysed as they come in.
Following the readability test, if any adjustments become necessary we will make recommendations for readability optimisation.
The result is an MDR-compliant SSCP along with readability test report (if relevant) meeting all regulatory requirements and ready for Notified Body review and EUDAMED submission.
We then provide Notified Body review support, standing 100% by our work and giving you complete peace of mind.
Our goal is full approval of your devices. Get in touch with our team for a free, confidential & no obligation discussion.
Mantra Systems has a dynamic team of subject matter experts with extensive experience in the SSCP process.
Our active clinicians will critically evaluate and summarise the safety and performance of your medical device, with specific insight into how your device impacts patient care. Their clinical expertise will address the challenge of writing SSCPs for both clinicians and lay persons. Having this unique international team also means we can successfully run multiple projects of any size and complexity.
We match each project to subject matter experts who work within the clinical field of the device under evaluation, providing the perfect foundation for a medical device SSCP.
We have over 50 subject matter experts based in the UK, Europe, USA, Canada, South Africa, and India. Their specialities include:
All aspects of communication from Mantra Systems have been excellent from initial contact to the conclusion of the work. There was excellent communication during the projects, included reviews and discussions helping to maintain the momentum and provide the required outcomes.
DSRegulatory & QA Manager, UK Manufacturer
Your service surpassed our expectations and added value across our organisation. We feel much better placed to prepare for the MDR.
KWChief Executive Officer, UK SaMD Company
SSCP is an entirely new requirement under the EU MDR that must be produced in relation to implantable and class III medical devices, except custom-made or investigational devices.
The main objective of the SSCP is to summarise clinical data and other information concerning the safety and clinical effectiveness of the medical device and to make it accessible to the general public in an appropriate form. It is written specifically for medical device end users, including both healthcare professionals and, if applicable, patients.
Since SSCP targets both audiences with varying degrees of expertise, it demands excellent technical writing abilities. To ensure that the patient-targeted SSCP is suitable for its intended audience, it is necessary to conduct a readability test.
Being an entirely new requirement under the MDR, SSCPs are a source of potential confusion and uncertainty amongst medical device manufacturers and regulators alike.
Furthermore, because an SSCP may need to include sections for different audiences (laypersons and clinicians), uncertainty over content is compounded by questions over styling and use of language.
SSCP success relies on the skill of the medical writer, implementation of an appropriate framework and high quality input documents.
The information presented in the SSCP should be sourced from the device's technical documents, known as input documents. A well-written CER is the kernel of a successful SSCP.
Requirements include:
The right strategy demands thorough knowledge of the clinical field of the subject device and expertise in working with clinical evidence.
Our team of skilled medical writers have years of clinical and regulatory experience along with deep knowledge of the EU MDR.
Get in touch for a free and open chat to see how we can support you with your compliance requirements.
Whatever you need, contact us today for a free & confidential discussion.
Mantra Systems have provided outstanding quality literature search reports and State of the Art appraisals for our medical devices; I would thoroughly recommend them.
TDDr. Trevor Day Principal Scientist, UK Procter & Gamble